中遠海控(01919.HK)續漲近半成 料中績少賺近75%大行指仍勝預期
中遠海控(01919.HK)料中績少賺近75%,但大摩指中期初步業績仍勝預期,且憧憬派中期息,短期可支撐中遠海控股價;匯豐研究也升中遠海控評級至「買入」及H股目標價升至9元。該股三連升,今早高見7.87元,創逾一個月高,現報7.76元,續升4.9%,成交已達2,134萬股;中遠海控A(601919.SH)也漲5.6%報10.04元民幣。
中遠海控發盈警,預計中期純利按年減少約74.5%至165.51億人民幣,主因是期內集裝箱航運業供需發生變化,中國出口集裝箱運價綜合指數(CCFI)均值下降69.31%,加上去年同期基數較高,導致公司上半年集裝箱航運業務收入下降及中績倒退。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.